LarryAWeinrauchMD

PubMed

• 1 citations
  Lipid Toxicity in the Cardiovascular-Kidney-Metabolic Syndrome (CKMS).
  John A D'Elia, Larry A Weinrauch
  Biomedicines. 2024-04-29
• 4 citations
  Hyperglycemia and Hyperlipidemia with Kidney or Liver Transplantation: A Review.
  John A D'Elia, Larry A Weinrauch
  Biology. 2023-08-29
• Preoperative Evaluations Before Transplantation-Essential Tools, Not Obstacles.
  Larry A Weinrauch, John A D'Elia
  JAMA Internal Medicine. 2023-07-01

Journal Articles

• Preoperative evaluations before transplantation – Essential tools, not obstacles.  
  Weinrauch, JAMA Internal Medicine, 5/15/2023
• Pollution and Organ Transplantation  
  Larry Weinrauch, MD, JACC: Cardiovascular Imaging
• Journal of the American College of Cardiology  
  Larry Weinrauch, MD, JACC: Cardiovascular Imaging
• Special Focus Issue: Blood Pressure Original Investigation Editorial Comment Epigenetics: Is the Mode of Conception a Marker for Future Cardiovascular Risk?∗  
  Larry A Weinrauch, Michael M Mendelson, ScienceDirect
• The autonomic nervous system and resistant hypertension  
  D’Elia JA, Weinrauch LA, Inter J Nephrol and Renovasc Dis, 1/1/2013
• Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure The ASTRONAUT Randomized Trial  
  Gheorghiade M, Bohm M, Greene SJ, Fonarow GC, Lewise EF, Zannad F, Solomon SD, Basciera F, Botha J, Hua TA, Gimpelewicz CR, Jaumont X, Lesogor A, Maggioni AP for the A..., JAMA, 3/20/2013
• C-reactive protein, fibrinogen and cardiovascular risk  
  Weinrauch LA, N Engl J Med, 1/1/2013
• Treatment of anemia with darbepoetin alfa in systolic heart failure  
  Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ; RED-HF Co..., N Engl J Med, 1/1/2013
• Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rati...  
  McMurray JJV, Packer M, . Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J , Shi VC , Solomon SD , Swedberg K, Zile MR, on behalf of the PARADIGM-HF Committees..., Eur J Heart Fail, 1/1/2013
• Do biologic markers predict cardiovascular endpoints in diabetic end stage renal disease? A prospective longitudinal study  
  Bayliss GP, Weinrauch LA, Gleason RE, Lee AT, D’Elia JA, Clinical Kidney Journal, 1/1/2013
• Editorial: Risk stratification of resistant hypertension in chronic kidney disease  
  Weinrauch LA, DeSai AS, Skali H, D’Elia JA, J Am Coll Cardiol, 1/1/2013
• Editorial: Ultrafiltration in End-Stage Heart Failure: Too little, too late?  
  Weinrauch LA, DeSai AS, Lewis EF, D’Elia JA, J Am Coll Cardiol, 1/1/2012
• Pathophysiology of Obesity-Related Renal Dysfunction Contributes to Diabetic Nephropathy  
  Bayliss G, Weinrauch LA, D’ Elia JA, Current Diabetes Reports, 1/1/2012
• The impact of a prior history of cardiovascular events on outcomes in patients on renal replacement therapy  
  Bayliss G, Roshan B, Ventrapragada S, Weinrauch LA, Gleason RE, D’ Elia JA, Int J Cardiol, 1/1/2012
• Stroke center designation and mortality  
  Weinrauch LA, Takeuchi M, JAMA, 1/1/2011
• Disruption of coronary vasomotor function: The coronary spasm syndrome  
  Moukarbel GV, Weinrauch LA, Cardiovascular Therapeutics, 1/1/2010
• What have we learned from trials of pulsatile insulin infusion?  
  Weinrauch LA, Gleason RE, D’Elia JA, Metabolism, 1/1/2010
• Pulsatile intermittent intravenous insulin therapy for attenuation of retinopathy and nephropathy in type 1 diabetes mellitus  
  Weinrauch LA, Sun J, Gleason RE, Boden GH, Creech RH, Dailey G, Kennedy FP, Weir MR, D’Elia JA, Metabolism, 1/1/2010
• Essay of Reform. Examine root causes of problems  
  Weinrauch LA, Modern Healthcare, 9/15/2009
• Editorial: Aiming for the best control of glycemia in patients with heart failure and type 2 diabetes: the “sweet spot”?  
  Weinrauch, LA, Lewis EF, J Am Coll Cardiol, 1/1/2009
• (Weinrauch LA) Aliskiren Trial in type 2 diabetes using cardio-renal endpoints (ALTITUDE): rationale and study design  
  Parving HH, Brenner BM, McMurray JJV, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA, Nephrol Dial Transplant, 1/1/2009
• Manifestation of renal disease in obesity: Pathophysiology of obesity-related dysfunction of the kidney  
  D’Elia JA, Roshan B, Maski M, Weinrauch LA, Inter J Nephrol and Renovasc Dis, 1/1/2009
• A Pilot Study To Assess Utility of Changes in Elements of the Diabetes Impact Management Scale in Evaluating Diabetic Patients for Progressive Nephropathy  
  Weinrauch LA, Bayliss G, Gleason RE, Lee AT, D’Elia JA, Metabolism, 1/1/2009
• Utilization of an Abbreviated Diabetes Impact Management Scale to Assess Change in Subjective Disability During a Trial of Pulsatile Insulin Delivery Demonstrates Benefit  
  Weinrauch LA, Bayliss G, Gleason RE, Lee AT, D’Elia JA, Metabolism, 1/1/2009
• Editorial: Mapping directions for the cardiorenal conundrum: where you end up depends on where you started, so where do we go from here?  
  Weinrauch LA, Lin J, Solomon SD, J Am Coll Cardiol, 1/1/2008
• Join now to see all

Books/Book Chapters

• Diabetic Renal Disease in Joslin’s Diabetes 
  Chapter: Diabetic Renal Disease in Joslin's Diabetes 
  Page 635 - 664D’Elia, J., Kaldany, A., Miller, D., and Weinrauch, LEditors: Christlieb, A., Bradley, R..Lea and Febiger, PhiladelphiaEdition 12th,1985

Abstracts/Posters

• Platelet activation is counterbalanced by fibrinogen lysis in study subjects with diabetes on hemodialysis and peritoneal dialysis
  Ventrapragada S, Roshan B, Bayliss G, Gleason RE, Weinrauch LA, D’Elia JA, J Am Soc Nephrol, 1/1/2011
• Usefulness of biomarkers of inflammation in predicting subsequent cardiovascular events in diabetic patients on renal replacement therapy
  Roshan B, Bayliss G, Ventrapragada S, Weinrauch LA, Gleason RE, D’Elia JA, J Am Soc Nephrol, 1/1/2011
• The impact of a prior history of cardiovascular events on outcomes in patients on renal replacement therapy (RRT)
  Bayliss G, Roshan B, Ventrapragada S, Weinrauch LA, Gleason RE, D’Elia JA, J Am Soc Nephrol, 1/1/2011
• Predictors of Heart Failure in Patients with Diabetes Mellitus and Chronic Kidney Disease
  Lewis EF, Solomon SD, McMurray JJV, Desai A, Hartley LH, Mielniczuk LM, Weinrauch LA Finn PV, Pfeffer MA, Eur Soc Cardiol, 1/1/2010
• Progression of retinopathy in type 1 diabetic patients with nephropathy: impact of changes in renal function over time
  LA Weinrauch, J Sun, RE Gleason, GH Boden, RH Creech, G Dailey, FP Kennedy, MR Weir, JA D’Elia, J Am Soc Nephrol, 1/1/2009
• Progression of retinopathy in type 1 diabetic patients with nephropathy: impact of glycemia control as measured by glycohemoglobin A1c
  LA Weinrauch, J Sun, RE Gleason, GH Boden, RH Creech, G Dailey, FP Kennedy, MR Weir, JA D’Elia, J Am Soc Nephrol, 1/1/2009
• Effect of pulsatile intravenous insulin infusion on the progression of retinopathy in type 1 diabetes with nephropathy, a pilot study
  LA Weinrauch, J Sun, RE Gleason, GH Boden, RH Creech, G Dailey, FP Kennedy, M. Weir, JA D’Elia, Diabetes, 1/1/2009
• Utility of Changes in Elements of the Diabetes Impact Management Scale in Evaluating Diabetic Patients for Progressive Nephropathy
  Bayliss G, Weinrauch LA, Gleason RE, Lee AT, D’Elia JA, J Am Soc Nephrol, 1/1/2007
• Cardiac And Quality Of Life Decisions In Diabetic Nephropathy: Impact Of Pulsatile Insulin Infusion
  Bayliss G, Weinrauch LA, Gleason RE, Burger AJ, D’Elia JA, J Am Soc Nephrol, 1/1/2007
• Pilot Study To Test The Effect Of Pulsatile Insulin On Cardiovascular Mechanisms That Might Contribute To Attenuation Of Renal Compromise In Type 1 Diabetic Nephropathy
  Bayliss G, Weinrauch LA, Gleason RE, Burger AJ, D’Elia JA, J Am Soc Nephrol, 1/1/2007
• Cardiac Autonomic Function Predicts Left Ventricular Structural And Functional Responses To Control Of Glycemia In Type 1 Diabetic Patients With Proteinuria
  D’Elia JA, Weinrauch LA, Gleason RE, Burger AJ, Lee, AT, Diabetes, 1/1/2005
• Relationship Between Left Ventricular Remodeling And Cardiac Autonomic Function In Type 1 Diabetic Patients With Proteinuria
  D’Elia JA, Weinrauch LA, Gleason RE, Burger AJ, Lee, AT, Diabetes, 1/1/2005
• Left Ventricular Mass Reduction in Type 1 Diabetes Mellitus
  Weinrauch LA, D’Elia JA, Gleason RE, Andrew Burger, Annette Lee, JACC, 1/1/2004
• Improved Glycemic Control Induces Regression of Left Ventricular Mass in Patients with Type 1 Diabetes Mellitus
  Aepfelbacher F, Yeon SB, Weinrauch LA, D’Elia J, Burger AJ, J Am Coll Card, 1/1/2002
• Prothromboembolic risk factors in a hemodialysis population
  D’Elia JA, Weinrauch LA, Gleason RE, Lipinska I, Pratt J, Tierney K, Lee AT, Tofler GH, American Federation of Medical Research. Biomedicine 2000. J Invest Med, 1/1/2000
• Low molecular weight fibrinogen in plasma of diabetic patients on hemodialysis is associated with leukocyte activation
  Lipinski B, Lipinska I, Weinrauch LA, D’Elia JA, J Submicroscopic Cytology and Pathology, 1/1/2000
• Platelet hyperaggregability of diabetic nephropathy is not affected by improved glycemic control
  Roshan B, Tofler GH, Weinrauch LA, Gleason RE, Keough JA, D’Elia JA, Diabetes, 1/1/1999
• Hemostatic Factors In Diabetic Nephropathy Patients with Stable Vs Unstable Renal Function
  D’Elia J, Weinrauch L, Lee AT, Keough J, Gleason RE, Lipinska I, Tofler G, J Am Soc Nephrol, 1/1/1997
• Autonomic Dysfunction Identifies Diabetic Nephropathy Patients at High Risk for Loss of Renal Function Due to Hypertension
  Weinrauch L, Kennedy F, Gleason R, Keough J, D’Elia J., Diabetes, 1/1/1997
• Reproducibility of Heart Rate Variability Analysis in Patients with Long Standing Type I Diabetes
  Burger A, Charlamb M, Hamer A, Weinrauch L, D’Elia J, J Am Coll Card, 1/1/1997
• Autonomic Dysfunction Identifies Diabetic Nephropathy Patients At High Risk For Loss Of Renal Function Due To Hypertension
  Weinrauch L, Kennedy F, Gleason R, Keough J, D’Elia J, American Federation of Clinical Research. J Invest Med, 1/1/1996
• Relationship Between Autonomic Function And Progression Of Renal Disease In Diabetics With Proteinuria
  Weinrauch L, Kennedy F, Gleason R, Keough J, D’Elia J, American Federation for Clinical Research. Biomedicine ‘96. J Invest Med, 1/1/1996
• Relationship of Heart Rate Variability And Lipid Profile In Type 1 Diabetics
  Hamer A, Burger A, Curran T, Choi C, Charlamb M, Weinrauch L, D’Elia J., American Federation for Clinical Research. Biomedicine ‘96. J Invest Med, 1/1/1996
• Prothrombotic Proteins Decrease With Intensive Insulin Therapy In Diabetic Nephropathy
  D’Elia J, Lee A, Weinrauch L, Gleason RE, Keough J, McKenna CA, Lipinska I, Tofler GH, American Federation for Clinical Research. Biomedicine ‘96. J Invest Med, 1/1/1996
• Elevated Cholesterol Is Associated With Abnormal Heart Rate Variability In Diabetics But Not In Patients With Coronary Disease
  Burger A, Hamer A, Choi C, D’Elia J, Weinrauch L, American Federation of Clinical Research. Biomedicine ‘96. J Invest Med, 1/1/1996
• Join now to see all

Lectures

• Hypertension-hype and attention to evidence 
  Lihue, Kauai, HI - 1/1/2007
• What is new in management of hypertensive catastrophes? 
  1/1/2007
• Insulinopenia, glomerular hypofiltration and sympathoadrenal instability, adverse effects on the cardiovascular system, Part 2: effects on left ventricular mass 
  1/1/2006
• Insulinopenia, glomerular hypofiltration and sympathoadrenal instability, adverse effects on the cardiovascular system, Part 1: an historical perspective 
  1/1/2006
• Early recognition and prevention of cardiovascular problems in women 
  Pali Momi, Aiea, HI - 1/1/2005
• Malignant Hypertension 
  1/1/2003
• Hypertensive Crises, hospital management of hypertension 
  1/1/2002
• Urgencies and emergencies in hypertensive management 
  1/1/2001
• Current Concepts in Hypertension 
  1/1/2000
• The Diabetic Heart 
  1/1/1999
• Cardiac Plumbing: Keeping the Blood Flowing and the Vessels Open 
  1/1/1999
• The EXCITE Trial, Use of Xemilofiban for the Prevention of Post Reperfusion Vascular Closure 
  1/1/1997
• Use of a New Class of Agents, the IIbIIIa Blockers 
  1/1/1997
• Cholesterol and the Management of Risk Factors in the Prevention of Heart, Vascular Disease and Stroke 
  1/1/1997
• Controlling Hypertension 
  1/1/1996
• Coronary Spasm and Ventricular Fibrillation 
  1/1/1996
• Role of the Valsalva Maneuver in the Prediction of a High Risk Group for Progressive Renal Dysfunction in Diabetes 
  1/1/1996
• Looking at your Heart 
  1/1/1996
• The Use of Cardiac Non Invasive Testing to Predict Microvascular Complications of Diabetes 
  1/1/1996
• Somatosensory Testing, Role of Vascular Tone in Regulation of Coagulation Factors 
  1/1/1995
• Cardiac Autonomic Diabetic Neuropathy in Diabetic Nephropathy 
  1/1/1994
• Cardiac Autonomic Diabetic Neuropathy, Role of Antihypertensive Agents and Diabetic Control 
  1/1/1994
• Protection of the Renal Transplant Patient from Sepsis by Antihypertensives 
  1/1/1994
• Diabetic Cardiac Autonomic Neuropathy, Baseline Circadian Variation? 
  1/1/1994
• Post-Operative Therapy of the Renal Transplant Recipient, the Effect of Antihypertensive Agents on Sepsis 
  1/1/1993
• Join now to see all

Other

• Jaw Pain Could Be Sign of Serious Heart Condition 
  Weinrauch LA
  http://www.healthcentral.com
  7/23/2008
• Rimonabant: Miracle Drug for Obesity? 
  Weinrauch LA
  http://www.healthcentral.com
  5/27/2008
• Should You Have an Automatic External Defibrillator in Your Home 
  Weinrauch LA
  http://www.healthcentral.com
  5/19/2008
• I can’t exercise because… 
  Weinrauch LA
  http://www.healthcentral.com
  5/14/2008
• Hot tubs and heart disease: Trouble or treatment? 
  Weinrauch LA
  http://www.healthcentral.com
  4/23/2008
• Emotional heartache can lead to real heart disease conditions 
  Weinrauch LA
  http://www.healthcentral.com
  4/8/2008
• My heart is thick, why? Causes of left ventricular hypertrophy 
  Weinrauch LA
  http://www.healthcentral.com
  4/6/2008
• Which exercises are best for your heart? 
  Weinrauch LA
  http://www.healthcentral.com
  3/31/2008
• Avoiding endocarditis prophylaxis at your next dental appointment 
  Weinrauch LA
  http://www.healthcentral.com
  3/11/2008
• Sex and heart disease: Can the two be mended? 
  Weinrauch LA
  http://www.healthcentral.com
  3/10/2008
• Feeling sick after waking in the morning? 
  Weinrauch LA
  http://www.healthcentral.com
  3/10/2008
• Tips for a heart-healthy lifestyle 
  Weinrauch LA
  http://www.healthcentral.com
  3/10/2008
• Black and blues: When NOT to worry… 
  Weinrauch LA
  http://www.healthcentral.com
  3/6/2008
• In denial: heart disease, breast cancer, and diabetes 
  Weinrauch LA
  http://www.healthcentral.com
  3/6/2008
• Investing in heart health 
  Weinrauch LA
  http://www.healthcentral.com
  3/6/2008
• Should patients who have heart disease take vaccinations for flu, pneumonia, and shingles? 
  Weinrauch LA
  http://www.healthcentral.com
  3/5/2008
• The "vapours," fainting, and the vagal reflex 
  Weinrauch LA
  http://www.healthcentral.com
  3/4/2008
• Heart Attack: Why People have Them and Why Doctor's Can't always Predict who Will 
  Weinrauch LA
  http://www.healthcentral.com
  2/25/2008
• Get the Most out of Your Cholesterol Medication 
  Weinrauch LA
  http://www.healthcentral.com
  2/13/2008
• What is Translational Research in Cardiology? 
  Weinrauch LA
  http://www.healthcentral.com
  2/11/2008
• Diets and the Heart: Is There a Best Diet? 
  Weinrauch LA
  http://www.healthcentral.com
  12/28/2007
• Health Care: Some important issues to consider this election cycle 
  Weinrauch LA
  http://www.healthcentral.com
  12/14/2007
• Heart-healthy advice that can enhance your life 
  Weinrauch LA
  http://www.healthcentral.com
  12/5/2007
• “Stent wars”: Everything you need to know about stents 
  Weinrauch LA
  http://www.healthcentral.com
  11/26/2007
• Ask the Expert: C-Reactive Protein Test and Undiagnosed Heart Disease 
  Weinrauch LA
  http://www.healthcentral.com
  11/14/2007
• Join now to see all